10 results on '"Chiu, Shih-Hsin"'
Search Results
2. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV.
- Author
-
Bhattacharya, Debika, Guo, Rong, Tseng, Chi-Hong, Emel, Lynda, Sun, Ren, Chiu, Shih-Hsin, Stranix-Chibanda, Lynda, Chipato, Tsungai, Mohtashemi, Neaka Z, Kintu, Kenneth, Manji, Karim P, Moodley, Dhayendre, Thio, Chloe L, Maldonado, Yvonne, and Currier, Judith S
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Pediatric AIDS ,Hepatitis ,Hepatitis - B ,HIV/AIDS ,Clinical Trials and Supportive Activities ,Infant Mortality ,Perinatal Period - Conditions Originating in Perinatal Period ,Prevention ,Pediatric ,Infectious Diseases ,Clinical Research ,Liver Disease ,Digestive Diseases ,Aetiology ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,2.2 Factors relating to the physical environment ,Infection ,Reproductive health and childbirth ,Good Health and Well Being ,Anti-HIV Agents ,Birth Weight ,Coinfection ,Double-Blind Method ,Female ,HIV Infections ,HIV-1 ,Hepatitis B ,Hepatitis B virus ,Humans ,Infectious Disease Transmission ,Vertical ,Nevirapine ,Pregnancy ,Viral Load ,Viremia ,pregnancy ,low birth weight ,hepatitis B virus viral load ,HIV/hepatitis B virus coinfection ,Sub-saharan Africa ,Paediatrics and Reproductive Medicine ,Public Health and Health Services ,Pediatrics ,Clinical sciences ,Paediatrics - Abstract
BackgroundThere is limited information on perinatal outcomes in HIV-hepatitis B virus (HBV) coinfection.MethodsHIV Prevention Trials Network (HPTN) 046 was a randomized double-blind placebo-controlled trial of perinatal transmission that evaluated 6 months of infant nevirapine versus placebo among breast-fed infants. Women living with HIV and their infants enrolled in sub-Saharan Africa from 2007 to 2010; 78% received antiretroviral therapy (ART). Maternal samples were tested for hepatitis B surface antigen (HBsAg). High and low HBV viral load (VL) was defined as ≥106 IU/mL and
- Published
- 2021
3. The Immunosuppressive Roles of PD-L1 during Influenza A Virus Infection.
- Author
-
Ning, Hongya, Chiu, Shih-Hsin, Xu, Xiaodong, Ma, Yanmei, Chen, Ji-Long, and Yang, Guihong
- Subjects
- *
IMMUNOSUPPRESSION , *PROGRAMMED death-ligand 1 , *VIRUS diseases , *INFLUENZA A virus, H1N1 subtype , *INFLUENZA A virus , *PLANT viruses - Abstract
The clinical benefits of targeting programmed death-ligand 1 (PD-L1) in various cancers represent a strategy for the treatment of immunosuppressive diseases. Here, it was demonstrated that the expression levels of PD-L1 in cells were greatly upregulated in response to H1N1 influenza A virus (IAV) infection. Overexpression of PD-L1 promoted viral replication and downregulated type-I and type-III interferons and interferon-stimulated genes. Moreover, the association between PD-L1 and Src homology region-2, containing protein tyrosine phosphatase (SHP2), during IAV/H1N1 infection was analyzed by employing the SHP2 inhibitor (SHP099), siSHP2, and pNL-SHP2. The results showed that the expressions of PD-L1 mRNA and protein were decreased under SHP099 or siSHP2 treatment, whereas the cells overexpressing SHP2 exhibited the opposite effects. Additionally, the effects of PD-L1 on the expression of p-ERK and p-SHP2 were investigated in PD-L1-overexpressed cells following WSN or PR8 infection, determining that the PD-L1 overexpression led to the decreased expression of p-SHP2 and p-ERK induced by WSN or PR8 infection. Taken together, these data reveal that PD-L1 could play an important role in immunosuppression during IAV/H1N1 infection; thus, it may serve as a promising therapeutic target for development of novel anti-IAV drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity.
- Author
-
Liao, Yuan, Goraya, Mohsan Ullah, Yuan, Xu, Zhang, Baoge, Chiu, Shih-Hsin, and Chen, Ji-Long
- Subjects
MEMBRANE proteins ,VIRAL proteins ,MEMBRANE fusion ,VIRUS diseases ,VIRAL genes - Abstract
Interferons (IFNs) play crucial roles in host defense against viral infections by inducing the expression of numerous IFN-stimulated genes (ISGs) that can activate host antiviral immunity. Interferon-inducible transmembrane proteins (IFITMs), a family of small transmembrane proteins, are critical ISG products. Compelling evidence has implicated that IFITMs can establish an innate immune state to eliminate pathogens efficiently. IFITM proteins can impede broad-spectrum viral infection through various mechanisms. It is generally believed that IFITMs can block the viral entry by suppressing viral membrane fusion. However, some findings indicated that IFITMs might also inhibit viral gene expression and viral protein synthesis and thereby impair viral replication. IFITMs may incorporate into virions during viral assembly and thus reduce the infectivity of nascent virions. The precise inhibitory mechanism of IFITMs on viral infection and replication still requires further exploration. In this review, we highlight the recent findings regarding critical roles of IFITMs in host-virus interaction. We also discuss the molecular mechanisms underlying their functions in antiviral responses. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. Identification of an Interferon-Stimulated Long Noncoding RNA (LncRNA ISR) Involved in Regulation of Influenza A Virus Replication.
- Author
-
Pan, Qidong, Zhao, Zhonghui, Liao, Yuan, Chiu, Shih-Hsin, Wang, Song, Chen, Biao, Chen, Na, Chen, Yuhai, and Chen, Ji-Long
- Subjects
NON-coding RNA ,INFLUENZA A virus ,VIRAL replication ,INTERFERON receptors ,VIRUS diseases ,BIODIVERSITY - Abstract
Long noncoding RNAs (lncRNAs) are involved in a diversity of biological processes. It is known that differential expression of thousands of lncRNAs occurs in host during influenza A virus (IAV) infection. However, only few of them have been well characterized. Here, we identified a lncRNA, named as interferon (IFN)-stimulated lncRNA (ISR), which can be significantly upregulated in response to IAV infection in a mouse model. A sequence alignment revealed that lncRNA ISR is present in mice and human beings, and indeed, we found that it was expressed in several human and mouse cell lines and tissues. Silencing lncRNA ISR in A549 cells resulted in a significant increase in IAV replication, whereas ectopic expression of lncRNA ISR reduced the viral replication. Interestingly, interferon-β (IFN-β) treatment was able to induce lncRNA ISR expression, and induction of lncRNA ISR by viral infection was nearly abolished in host deficient of IFNAR1, a type I IFN receptor. Furthermore, the level of IAV-induced lncRNA ISR expression was decreased either in retinoic acid-inducible gene I (RIG-I) knockout A549 cells and mice or by nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) inhibitor treatment. Together, these data elucidate that lncRNA ISR is regulated by RIG-I-dependent signaling that governs IFN-β production during IAV infection, and has an inhibitory capacity in viral replication. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.
- Author
-
Wu, Chung-Chun, Fang, Chih-Yeu, Huang, Sheng-Yen, Chiu, Shih-Hsin, Lee, Chia-Huei, and Chen, Jen-Yang
- Subjects
DISEASE relapse prevention ,CARCINOGENS ,EPITHELIAL cells ,EPSTEIN-Barr virus ,GENOMICS ,NASOPHARYNX tumors ,DISEASE progression ,PREVENTION - Abstract
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma derived from the epithelium of the post-nasal cavity, with a unique geographic and ethnic distribution. Epstein–Barr virus (EBV) is an etiological agent of NPC, but how it contributes to carcinogenesis is not completely clear. Although it is thought that EBV latency participates in the development of NPC, increasing evidence reveals that the lytic cycle also plays an important role in the carcinogenic process. In this review, we summarize our recent studies on how EBV reactivation causes genomic instability and accelerates tumorigenesis in epithelial cells. The roles of three lytic genes, namely,
BRLF1 ,BGLF5 andBALF3 , in this process are also introduced. Moreover, blocking EBV reactivation using natural compounds may help delay the progression of NPC tumorigenesis. These studies provide a new insight into NPC carcinogenesis and raise the possibility that inhibition of EBV reactivation may be a novel approach to prevent the relapse of NPC. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
7. Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-Saharan Africa.
- Author
-
Bhattacharya D, Guo R, Tseng CH, Emel L, Sun R, Zhang TH, Chiu SH, Stranix-Chibanda L, Chipato T, Ship H, Mohtashemi NZ, Kintu K, Manji KP, Moodley D, Maldonado Y, Currier JS, and Thio CL
- Subjects
- Female, Humans, Infant, Pregnancy, Africa South of the Sahara epidemiology, Anti-Retroviral Agents therapeutic use, DNA, Viral, Hepatitis B e Antigens therapeutic use, Hepatitis B Surface Antigens, Hepatitis B virus genetics, Infectious Disease Transmission, Vertical prevention & control, Lamivudine therapeutic use, Retrospective Studies, Viral Load, Coinfection drug therapy, Hepatitis B drug therapy, Hepatitis B epidemiology, HIV Infections complications, HIV Infections drug therapy, HIV Infections epidemiology
- Abstract
Objectives: To describe the clinical and virologic characteristics of HIV-HBV coinfection, including the predictors of high maternal HBV viral load in pregnant women with HIV in sub-Saharan Africa (SSA)., Methods: HPTN 046 was a HIV perinatal transmission clinical trial evaluating infant nevirapine vs. placebo. Women-infant pairs ( n = 2016) were enrolled in SSA from 2007 to 2010; 1579 (78%) received antiretrovirals (ARV). Maternal delivery samples were retrospectively tested for hepatitis B surface antigen (HBsAg), and if positive, were tested for hepatitis B e antigen (HBeAg) and HBV viral load (VL). High HBV VL was defined as ≥10 6 IU/ml., Results: Overall, 4.4% (88/2016) had HBV co-infection, with geographic variability ranging from 2.4% to 8.7% ( P < 0.0001); 25% (22/88) were HBeAg positive with prevalence in countries ranging from 10.5% to 39%. Fifty-two percentage (40/77) of those with HBV received ARV, the majority (97%) received 3TC as the only HBV active agent. HBeAg positivity was associated with high maternal HBV VL, odds ratio (OR) 37.0, 95% confidence interval (CI) 5.4-252.4. Of those with high HBV VL, 40% (4/10) were receiving HBV active drugs (HBV-ARV). HBV drug resistance occurred in 7.5% (3/40) receiving HBV-ARV., Conclusions: In SSA, HBV co-infection is common in pregnant women with HIV. HBsAg and HBeAg prevalence vary widely by country in this clinical trial cohort. HBeAg is a surrogate for high HBV viral load. HBV drug resistance occurred in 7.5% receiving HBV-ARV with lamivudine as the only HBV active agent. These findings reinforce the importance of HBsAg screening and early treatment with two active agents for HBV., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
- Author
-
Wang Q, Pan W, Wang S, Pan C, Ning H, Huang S, Chiu SH, and Chen JL
- Subjects
- A549 Cells, Animals, ErbB Receptors antagonists & inhibitors, Extracellular Signal-Regulated MAP Kinases antagonists & inhibitors, Extracellular Signal-Regulated MAP Kinases metabolism, Humans, Immune Evasion, Interferons metabolism, Mice, Orthomyxoviridae Infections virology, Phosphorylation, Protein Tyrosine Phosphatase, Non-Receptor Type 11 genetics, Signal Transduction immunology, Virus Replication, ErbB Receptors metabolism, Immunity, Innate, Influenza A virus physiology, Orthomyxoviridae Infections immunology, Protein Tyrosine Phosphatase, Non-Receptor Type 11 immunology
- Abstract
Influenza A virus (IAV) is a highly contagious pathogen, causing acute respiratory illnesses in human beings and animals and frequently giving rise to epidemic outbreaks. Evasion by IAV of host immunity facilitates viral replication and spread, which can be initiated through various mechanisms, including epidermal growth factor receptor (EGFR) activation. However, how EGFR mediates the suppression of antiviral systems remains unclear. Here, we examined host innate immune responses and their relevant signaling to EGFR upon IAV infection. IAV was found to induce the phosphorylation of EGFR and extracellular signal-regulated kinase (ERK) at an early stage of infection. Inhibition of EGFR or ERK suppressed the viral replication but increased the expression of type I and type III interferons (IFNs) and interferon-stimulated genes (ISGs), supporting the idea that IAV escapes from antiviral innate immunity by activating EGFR/ERK signaling. Meanwhile, IAV infection also induced the activation of Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2). Pharmacological inhibition or small interfering RNA (siRNA)-based silencing of SHP2 enhanced the IFN-dependent antiviral activity and reduced virion production. Furthermore, knockdown of SHP2 attenuated the EGFR-mediated ERK phosphorylation triggered by viral infection or EGF stimulation. Conversely, ectopic expression of constitutively active SHP2 noticeably promoted ERK activation and viral replication, concomitant with diminished immune function. Altogether, the results indicate that SHP2 is crucial for IAV-induced activation of the EGFR/ERK pathway to suppress host antiviral responses. IMPORTANCE Viral immune evasion is the most important strategy whereby viruses evolve for their survival. This work shows that influenza A virus (IAV) suppressed the antiviral innate immunity through downregulation of IFNs and ISGs by activating EGFR/ERK signaling. Meanwhile, IAV also induced the activation of protein tyrosine phosphatase SHP2, which was found to be responsible for modulating the EGFR-mediated ERK activity and subsequent antiviral effectiveness both in vitro and in vivo The results suggest that SHP2 is a key signal transducer between EGFR and ERK and plays a crucial role in suppressing host innate immunity during IAV infection. The finding enhances our understanding of influenza immune evasion and provides a new therapeutic approach to viral infection., (Copyright © 2021 American Society for Microbiology.)
- Published
- 2021
- Full Text
- View/download PDF
9. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
- Author
-
Chiu SH, Wu CC, Fang CY, Yu SL, Hsu HY, Chow YH, and Chen JY
- Subjects
- Animals, Antineoplastic Agents pharmacology, Carcinoma, Cell Line, Tumor, Cell Movement, Cell Proliferation, DNA Copy Number Variations, DNA Damage, DNA-Binding Proteins genetics, Doxycycline pharmacology, Endodeoxyribonucleases genetics, Epstein-Barr Virus Infections genetics, Epstein-Barr Virus Infections metabolism, Epstein-Barr Virus Infections pathology, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Genome-Wide Association Study, Herpesvirus 4, Human genetics, Herpesvirus 4, Human pathogenicity, Host-Pathogen Interactions, Humans, Mice, Inbred NOD, Mice, SCID, Micronuclei, Chromosome-Defective, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms drug therapy, Nasopharyngeal Neoplasms genetics, Nasopharyngeal Neoplasms metabolism, Nasopharyngeal Neoplasms pathology, RNA Interference, Time Factors, Transfection, Tumor Burden, Viral Proteins genetics, Xenograft Model Antitumor Assays, Cell Transformation, Viral, DNA-Binding Proteins metabolism, Endodeoxyribonucleases metabolism, Epstein-Barr Virus Infections virology, Genomic Instability, Herpesvirus 4, Human metabolism, Nasopharyngeal Neoplasms virology, Viral Proteins metabolism
- Abstract
Nasopharyngeal carcinoma (NPC) is a head and neck cancer prevalent throughout Southern China and Southeast Asia. Patient death following relapse after primary treatment remains all too common but the cause of NPC relapse is unclear. Clinical and epidemiological studies have revealed the high correlation among NPC development, Epstein-Barr virus (EBV) reactivation and host genomic instability. Previously, recurrent EBV reactivation was shown to cause massive genetic alterations and enhancement of tumor progression in NPC cells and these may be required for NPC relapse. Here, EBV BALF3 has the ability to induce micronuclei and DNA strand breaks. After recurrent expression of BALF3 in NPC cells, genomic copy number aberrations, determined by array-based comparative genomic hybridization, had accumulated to a significant extent and tumorigenic features, such as cell migration, cell invasion and spheroid formation, increased with the rounds of induction. In parallel experiments, cells after highly recurrent induction developed into larger tumor nodules than control cells when inoculated into NOD/SCID mice. Furthermore, RNA microarrays showed that differential expression of multiple cancer capability-related genes and oncogenes increased with recurrent BALF3 expression and these changes correlated with genetic aberrations. Therefore, EBV BALF3 is a potential factor that mediates the impact of EBV on NPC relapse.
- Published
- 2014
- Full Text
- View/download PDF
10. Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.
- Author
-
Chiu SH, Wu MC, Wu CC, Chen YC, Lin SF, Hsu JT, Yang CS, Tsai CH, Takada K, Chen MR, and Chen JY
- Subjects
- Cations, Divalent metabolism, Enzyme Activators metabolism, Magnesium metabolism, Manganese metabolism, Endodeoxyribonucleases metabolism, Endonucleases metabolism, Herpesvirus 4, Human enzymology, Herpesvirus 4, Human physiology, Viral Proteins metabolism, Virus Assembly, Virus Replication
- Abstract
Unlabelled: Epstein-Barr virus (EBV) lytic replication involves complex processes, including DNA synthesis, DNA cleavage and packaging, and virion egress. These processes require many different lytic gene products, but the mechanisms of their actions remain unclear, especially for DNA cleavage and packaging. According to sequence homology analysis, EBV BALF3, encoded by the third leftward open reading frame of the BamHI-A fragment in the viral genome, is a homologue of herpes simplex virus type 1 UL28. This gene product is believed to possess the properties of a terminase, such as nucleolytic activity on newly synthesized viral DNA and translocation of unit length viral genomes into procapsids. In order to characterize EBV BALF3, the protein was produced by and purified from recombinant baculoviruses and examined in an enzymatic reaction in vitro, which determined that EBV BALF3 acts as an endonuclease and its activity is modulated by Mg(2+), Mn(2+), and ATP. Moreover, in EBV-positive epithelial cells, BALF3 was expressed and transported from the cytoplasm into the nucleus following induction of the lytic cycle, and gene silencing of BALF3 caused a reduction of DNA packaging and virion release. Interestingly, suppression of BALF3 expression also decreased the efficiency of DNA synthesis. On the basis of these results, we suggest that EBV BALF3 is involved simultaneously in DNA synthesis and packaging and is required for the production of mature virions., Importance: Virus lytic replication is essential to produce infectious virions, which is responsible for virus survival and spread. This work shows that an uncharacterized gene product of the human herpesvirus Epstein-Barr virus (EBV), BALF3, is expressed during the lytic cycle. In addition, BALF3 mediates an endonucleolytic reaction and is involved in viral DNA synthesis and packaging, leading to influence on the production of mature virions. According to sequence homology and physical properties, the lytic gene product BALF3 is considered a terminase in EBV. These findings identify a novel viral gene with an important role in contributing to a better understanding of the EBV life cycle.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.